Frederic Pla - 23 Mar 2024 Form 4 Insider Report for Akoya Biosciences, Inc. (AKYA)

Reporting relationship: Chief Operating Officer
Issuer ticker: AKYA
Reported as of: 23 Mar 2024
Net transaction value: -$9,609
SEC form: 4
Accepted by SEC: 25 Mar 2024, 17:16:11 UTC
Prior SEC filing: 01 Mar 2024
Source filing: View source filing
Reporting owner signature: /s/ Frederic Pla, by Brian McKelligon, as Attorney-in-Fact

Key filing fact

Frederic Pla filed Form 4 for Akoya Biosciences, Inc. (AKYA) on 25 Mar 2024.

Key facts

This page summarizes Frederic Pla's Form 4 filing for Akoya Biosciences, Inc. (AKYA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 25 Mar 2024, 17:16.

Change

Previous filing in this sequence was filed on 01 Mar 2024.
Current net transaction value: -$9,609.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AKYA transaction

Common Stock

Tax liability

Transaction value: $9,609
Shares: -2,006
Change %: -1.9%
Price: $4.79
Shares after: 101,500
Date: 23 Mar 2024
Ownership: Direct
Footnotes: F1

AKYA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 20,000
Date: 23 Mar 2024
Ownership: By The Pla Family Trust dtd 8/7/14

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares withheld to cover taxes on a restricted stock unit award previously granted March 23, 2022, which vests in four (4) annual equal installments beginning on March 23, 2023 and annually thereafter until fully vested.